Skip to main content
SpringerLink
Log in

European Society of Cardiology

Cardiovascular Health in Women; 3–7 September; Stockholm, Sweden

  • Meeting Report
  • Published:
International Journal of Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Further details on the society can be found at the website: http://www.escardio.org.

  2. The Bristol-Myers Squibb Foundation is supporting the ‘Women at Heart’ initiative.

References

  1. Jochmann N, Stangl K, Garbe E, et al. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 2005; 26: 1585–95

    Article  PubMed  CAS  Google Scholar 

  2. Willenheimer R, van Veldhuisen DJ, Silke B, et al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence. CIBIS III. Circulation 2005 Oct 18; 112 (16): 2426–35

    Article  PubMed  CAS  Google Scholar 

  3. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA): a multicenter randomized controlled trial. Lancet 2005; 366: 907–13

    Article  PubMed  Google Scholar 

  4. Poulter NR, Wedel H, Dahlöf B, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005; 366: 895–906

    Article  PubMed  Google Scholar 

  5. Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) [online]. Available from URL: http://www.ascotstudy.org [Accessed 2005 Oct 24]

  6. Poulter NR, Sever PS. Anglo-Scandinavian Cardiac Outcomes Trial: history, results and implications for the management of high blood pressure. Birmingham: Sherborne Gibbs Ltd, 2005

    Google Scholar 

  7. 2002 World Health Report. Geneva: World Health Organization, 2002

  8. Van Ganse E, Laforest L, Alemao E, et al. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the return on Expenditure Achieved for Lipid Therapy (REALITY) study. Curr Med Res Opinions 2005; 21: 1389–99

    Article  Google Scholar 

  9. Brohet C, Banai S, Alings AMW, et al. LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia. Curr Med Res 2005; 21: 571–8

    Article  CAS  Google Scholar 

  10. Murdoch D, Scott LJ. Ezetimibe/simvastatin: a review of its use in management of hypercholesterolemia. Am J Cardiovasc Drugs 2004; 4: 405–22

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr Kitler is a consultant at Associates for Business and Research (ABR), which specialises in all issues relating to the pharmaceutical and biotechnology industry. She can be contacted at fredfifijdk@yahoo.com; phone +41 21 824 1419.

Author information

Authors and Affiliations

  1. Associates for Business and Research, Gilly, Switzerland

    Mary Ellen Kitler

Authors
  1. Mary Ellen Kitler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitler, M.E. European Society of Cardiology. Int J Pharm Med 19, 239–242 (2005). https://doi.org/10.2165/00124363-200519040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00124363-200519040-00006

Keywords

Search

Navigation